BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37141697)

  • 41. Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.
    Ji X; Tao R; Sun LY; Xu XL; Ling W
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3152-3165. PubMed ID: 32271433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA DUXAP9-206 directly binds with Cbl-b to augment EGFR signaling and promotes non-small cell lung cancer progression.
    Zhu T; An S; Choy MT; Zhou J; Wu S; Liu S; Liu B; Yao Z; Zhu X; Wu J; He Z
    J Cell Mol Med; 2019 Mar; 23(3):1852-1864. PubMed ID: 30515972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p.
    Wu W; Zhao Y; Gao E; Li Y; Guo X; Zhao T; He W; Zhang H
    J Cell Mol Med; 2020 Jan; 24(1):441-450. PubMed ID: 31721438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p.
    Zhang L; Chi B; Chai J; Qin L; Zhang G; Hua P; Jin C
    Mol Biotechnol; 2021 Oct; 63(10):933-940. PubMed ID: 34115289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The long non-coding RNA LSINCT5 promotes malignancy in non-small cell lung cancer by stabilizing HMGA2.
    Tian Y; Zhang N; Chen S; Ma Y; Liu Y
    Cell Cycle; 2018; 17(10):1188-1198. PubMed ID: 29883241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer.
    Feng J; Sun Y; Zhang EB; Lu XY; Jin SD; Guo RH
    Int J Clin Exp Pathol; 2015; 8(10):12268-75. PubMed ID: 26722412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway.
    Sun CC; Zhu W; Li SJ; Hu W; Zhang J; Zhuo Y; Zhang H; Wang J; Zhang Y; Huang SX; He QQ; Li DJ
    Genome Med; 2020 Sep; 12(1):77. PubMed ID: 32878637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functions of lncRNA DUXAP8 in non-small cell lung cancer.
    Wu C; Song W; Wang Z; Wang B
    Mol Biol Rep; 2022 Mar; 49(3):2531-2542. PubMed ID: 35031926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA JPX correlates with poor prognosis and tumor progression in non-small-cell lung cancer by interacting with miR-145-5p and CCND2.
    Jin M; Ren J; Luo M; You Z; Fang Y; Han Y; Li G; Liu H
    Carcinogenesis; 2020 Jul; 41(5):634-645. PubMed ID: 31253987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNA ATB expedites non-small cell lung cancer progression by the miR-200b/fibronectin 1 axis.
    Sun S; Zou Y; Xu N; Wang K; Rong S; Lv J; Hu B; Mai Y; Zhu D; Ding L
    J Clin Lab Anal; 2023 Apr; 37(4):e24822. PubMed ID: 36806318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long Non-Coding RNA Brain Cytoplasmic RNA 1 Acts as an Oncogene and Regulates Cell Proliferation and Metastasis in Non-Small Cell Lung Cancer.
    Wang Y; Bai W; Wang M; Yu T; Zhang W
    J Nanosci Nanotechnol; 2019 Apr; 19(4):1978-1985. PubMed ID: 30486938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway.
    Pan W; Li W; Zhao J; Huang Z; Zhao J; Chen S; Wang C; Xue Y; Huang F; Fang Q; Wang J; Brand D; Zheng SG
    Mol Oncol; 2019 Oct; 13(10):2246-2258. PubMed ID: 31368655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.
    Zhang B; Tao F; Zhang H
    Mol Med Rep; 2018 Apr; 17(4):4899-4908. PubMed ID: 29393472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positive feedback loop of lncRNA LINC01296/miR-598/Twist1 promotes non-small cell lung cancer tumorigenesis.
    Xu L; Wei B; Hui H; Sun Y; Liu Y; Yu X; Dai J
    J Cell Physiol; 2019 Apr; 234(4):4563-4571. PubMed ID: 30240003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A long non-coding RNA LNBC3 facilitates non-small cell lung cancer progression by stabilizing BCL6.
    Shen J; Ma J; Li J; Wang X; Wang Y; Ma J
    J Clin Lab Anal; 2020 Apr; 34(4):e23122. PubMed ID: 31743519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway.
    Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W
    J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion.
    Nie FQ; Zhu Q; Xu TP; Zou YF; Xie M; Sun M; Xia R; Lu KH
    Tumour Biol; 2014 Aug; 35(8):7587-94. PubMed ID: 24793017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
    Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
    Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.